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Résumé en
anglais
Young mice overexpressing Runx2 specifically in cells of the osteoblastic lineage
failed to gain bone mass and exhibited a dramatic increase in bone resorption,
leading to severe osteopenia and spontaneous vertebral fractures. The objective of
the current study was to determine whether treatment with a bisphosphonate
(risedronate, Ris), which reduces fractures in postmenopausal as well as in juvenile
osteoporosis, was able to improve bone quality and reduce vertebral fractures in
mice overexpressing Runx2. Four-week-old female Runx2 mice received Ris at 2 and
10 μg/kg subcutaneously twice a week for 12 weeks. Runx2 and wild-type mice
received vehicle (Veh) as control. We measured the number of new fractures by X-
ray and bone mineral density (BMD) by DEXA. We evaluated bone quality by
histomorphometry, micro-CT, and Fourier transform infrared imaging (FTIRI). Ris at
20 μg/kg weekly significantly reduced the average number of new vertebral
fractures compared to controls. This was accompanied by significantly increased
BMD, increased trabecular bone volume, and reduced bone remodeling (seen in
indices of bone resorption and formation) in the vertebrae and femoral metaphysis
compared to Runx2 Veh. At the femur, Ris also increased cortical thickness. Changes
in collagen cross-linking seen on FTIRI confirmed that Runx2 mice have accelerated
bone turnover and showed that Ris affects the collagen cross-link ratio at both
forming and resorbing sites. In conclusion, young mice overexpressing Runx2 have
high bone turnover-induced osteopenia and spontaneous fractures. Ris at 20 μg/kg
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